Thurston Springer Miller Herd & Titak’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.9K Hold
10
﹤0.01% 1020
2026
Q1
$4.73K Hold
10
﹤0.01% 1058
2025
Q4
$4.67K Buy
+10
New +$4.64K ﹤0.01% 1110
2025
Q3
Sell
-2
Closed -$766 897
2025
Q2
$766 Hold
2
﹤0.01% 1523
2025
Q1
$691 Sell
2
-15
-88% -$4.82K ﹤0.01% 1559
2024
Q4
$5.1K Buy
17
+4
+31% +$1.4K ﹤0.01% 1013
2024
Q3
$5.28K Buy
13
+11
+550% +$4.03K ﹤0.01% 1175
2024
Q2
$642 Buy
+2
New +$650 ﹤0.01% 1441

Other funds holding HCA

Thurston Springer Miller Herd & Titak's HCA Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak held its HCA Healthcare (HCA) position steady in Q2 2026 at 10 shares worth $3.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1020.

Thurston Springer Miller Herd & Titak first reported a position in HCA in Q2 2024 and has held it in 8 quarters since. The position peaked at $5.28K in Q3 2024. 427 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Thurston Springer Miller Herd & Titak held 10 shares of HCA Healthcare worth $3.9K as of Q2 2026.
  • Thurston Springer Miller Herd & Titak left its HCA Healthcare share count unchanged in Q2 2026.
  • HCA Healthcare made up ﹤0.01% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #1020 holding.
  • Thurston Springer Miller Herd & Titak first reported a position in HCA Healthcare in Q2 2024 and has held it in 8 quarters since.
  • Thurston Springer Miller Herd & Titak's HCA Healthcare position peaked at $5.28K in Q3 2024.
  • 427 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.